POST Online Media Lite Edition


Egalet appoints Robert Roche to board of directors

Staff Writer |
Wayne, Pa., USA - December 9, 2016, Wayne, Pa., USA - Egalet Corporation, a specialty pharmaceutical company, announced the appointment of Robert P. Roche, Jr. to its board of directors.

Article continues below

Over the past six years, Mr. Roche has used his decades of commercial and marketing experience as the founding member of Robert Roche Associates LLC, a consulting firm that provides guidance to the pharmaceutical and healthcare industries.

Prior to that Mr. Roche led commercial operations at Cephalon Inc. for fifteen years, and held the position of executive vice president starting in 2005.

Before joining Cephalon Mr. Roche served as director and vice president of worldwide strategic product development for SmithKline Beecham's central nervous system and gastrointestinal products business. He was also managing director of SmithKline's pharmaceutical operations in the Philippines.

Prior to that he held senior marketing positions in Canada and Spain and had product planning responsibilities for SmithKline in Latin America.

Mr. Roche began his pharmaceutical career in 1982 with SmithKline & French as a U.S. pharmaceutical sales representative. He is a member of the board of directors of Aratana Therapeutics, Antares Pharma, Paragon Bioservices, Inc. and Bryn Mawr Hospital.

LATEST 5 MOVES FROM Pennsylvania 

What to read next

Egalet appoints Mark Strobeck as EVP and COO
Aratana Therapeutics adds Robert P. Roche, Jr. to board
Egalet appoints Patrick Shea as chief commercial officer